Long Focus Capital Management, LLC Bristol Myers Squibb CO Transaction History
Long Focus Capital Management, LLC
- $2.88 Billion
- Q1 2025
A detailed history of Long Focus Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 1,190,000 shares of BMY stock, worth $55.8 Million. This represents 11.17% of its overall portfolio holdings.
Number of Shares
1,190,000Holding current value
$55.8 Million% of portfolio
11.17%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...